Biochemical definitions of disease activity in acromegaly

Growth Hormone and IGF Research

Volumn 13, Issue 2-3, 2003, Pages 98-103

  Conceição, Flavia Lucia ^a,b   Fisker, Sanne ^a   Christiansen, Jens Sandahl ^a   Astrup, Jens ^a   Weeke, Jørgen ^a   Jørgensen, Jens Otto Lunde ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Acromegaly; Cure criteria; GH profile

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

ACROMEGALY; ADULT; ARTICLE; BIOCHEMISTRY; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; GROWTH HORMONE RELEASE; HORMONE DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STANDARD; TRANSSPHENOIDAL SURGERY; TREATMENT OUTCOME;

EID: 0037498404     PISSN: 10966374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1096-6374(03)00009-1     Document Type: Article

References (21)

1. A. Giustina, A. Barkan, F.F. Casanueva, F. Cavagnini, L. Frohman, K. Ho, et al., Criteria for cure of acromegaly: a consensus statement, J. Clin. Endocrinol. Metab. 85 (2) (2000) 526-529.
2. S. Yamada, T. Aiba, K. Takada, Y. Ozawa, T. Shimizu, S. Sawano, et al., Retrospective analysis of long-term surgical results in acromegaly: preoperative and postoperative factors predicting outcome, Clin. Endocrinol. (Oxf.) 45 (3) (1996) 291-298.
3. A.S. Bates, W. Van't Hoff, J.M. Jones, R.N. Clayton, An audit of outcome of treatment in acromegaly, Q. J. Med. 86 (5) (1993) 293-299.
4. C. Rajasoorya, I.M. Holdaway, P. Wrightson, D.J. Scott, H.K. Ibbertson, Determinants of clinical outcome and survival in acromegaly, Clin. Endocrinol. (Oxf.) 41 (1) (1994) 95-102.
5. A. Abosch, J.B. Tyrrell, K.R. Lamborn, L.T. Hannegan, C.B. Applebury, C.B. Wilson, Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and long-term results, J. Clin. Endocrinol. Metab. 83 (10) (1998) 3411-3418.
6. J. Frystyk, B. Dinesen, H. Orskov, Non-competitive time-resolved immunofluorometric assays for determination of human insulin-like growth factor I and II, Growth Regul. 5 (4) (1995) 169-176.
7. M.H. Zweig, G. Campbell, Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine, Clin. Chem. 39 (4) (1993) 561-577.
8. I.M. Chapman, M.L. Hartman, M. Straume, M.L. Johnson, J.D. Veldhuis, M.O. Thorner, Enhanced sensitivity growth hormone (GH) chemiluminescence assay reveals lower postglucose nadir GH concentrations in men than women, J. Clin. Endocrinol. Metab. 78 (6) (1994) 1312-1319.
9. P.U. Freda, K.D. Post, J.S. Powell, S.L. Wardlaw, Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly, J. Clin. Endocrinol. Metab. 83 (11) (1998) 3808-3816.
10. B. Swearingen, F.G. Barker, L. Katznelson, B.M. Biller, S. Grinspoon, A. Klibanski, et al., Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly, J. Clin. Endocrinol. Metab. 83 (10) (1998) 3419-3426.
11. K.Y. Ho, A.J. Weissberger, Characterization of 24-hour growth hormone secretion in acromegaly: implications for diagnosis and therapy, Clin. Endocrinol. (Oxf.) 41 (1) (1994) 75-83.
12. R. Fahlbusch, J. Honegger, M. Buchfelder, Surgical management of acromegaly, Endocrinol. Metab. Clin. North Am. 21 (3) (1992) 669-692.
13. I.A. Osman, R.A. James, S. Chatterjee, D. Mathias, P. Kendall-Taylor, Factors determining the long-term outcome of surgery for acromegaly, QJM 87 (10) (1994) 617-623.
14. D. Jenkins, I. O'Brien, A. Johnson, R. Shakespear, M.C. Sheppard, P.M. Stewart, The Birmingham pituitary database: auditing the outcome of the treatment of acromegaly, Clin. Endocrinol. (Oxf.) 43 (5) (1995) 517-522.
15. R. Sheaves, P. Jenkins, P. Blackburn, A.H. Huneidi, F. Afshar, S. Medbak, et al., Outcome of transsphenoidal surgery for acromegaly using strict criteria for surgical cure, Clin. Endocrinol. (Oxf.) 45 (4) (1996) 407-413.
16. A. Colao, B. Merola, D. Ferone, G. Lombardi, Acromegaly, J. Clin. Endocrinol. Metab. 82 (9) (1997) 2777-2781.
17. S. Ahmed, M. Elsheikh, I.M. Stratton, R.C. Page, C.B. Adams, J.A. Wass, Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experience, Clin. Endocrinol. (Oxf.) 50 (5) (1999) 561-567.
18. J. Kreutzer, M.L. Vance, M.B. Lopes, E.R. Laws Jr., Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria, J. Clin. Endocrinol. Metab. 86 (9) (2001) 4072-4077.
19. B.G. van den, M. Frolich, J.D. Veldhuis, F. Roelfsema, Growth hormone secretion in recently operated acromegalic patients, J. Clin. Endocrinol. Metab. 79 (6) (1994) 1706-1715.
20. M. Semer, A.C. Faria, M. Nery, L.R. Salgado, M. Knoepfelmacher, B.L. Wajchenberg, et al., Growth hormone pulsatility in active and cured acromegalic subjects, J. Clin. Endocrinol. Metab. 80 (12) (1995) 3767-3770.
21. M.L. Hartman, J.D. Veldhuis, M.L. Vance, A.C. Faria, R.W. Furlanetto, M.O. Thorner, Somatotropin pulse frequency and basal concentrations are increased in acromegaly and are reduced by successful therapy, J. Clin. Endocrinol. Metab. 70 (5) (1990) 1375-1384.